Sudeep Pharma IPO worth ₹895 Cr, will open for subscription from 21 Nov to 25 Nov 2025. Sudeep Pharma IPO allotment is expected on 26 Nov and shares are likely to be listed on BSE & NSE on 28 Nov. Price band for the IPO is set between ₹563 to ₹593 per share and Sudeep Pharma IPO GMP today stands at 19.39%.
Sudeep Pharma IPO GMP Live Rates Day by Day
Sudeep Pharma GMP today (20th Nov 2025) stands at 19.39%. GMP values change daily and we’ll keep you updated with the latest figures.
Remember, Grey Market Premium is an unofficial price at which an IPO trades before listing, offering an early hint of its performance. A positive GMP indicates potential gains, while a negative GMP signals a discount. Since GMP is highly volatile, investors should not rely on it alone and must consider other factors before investing in Sudeep Pharma IPO.
GMP figures are for news purposes only. We neither trade nor recommend trading in the grey market.
Sudeep Pharma IPO Details
- Sudeep Pharma’s IPO is worth ₹895 Cr, which is a combination of fresh issue of ₹95 Cr and OFS of ₹800 Cr.
- Sudeep Pharma’s IPO will open for subscription on 21 Nov 2025 and close on 25 Nov 2025. And the price band is set between ₹563- ₹593.
- Sudeep Pharma’s IPO allotment is likely to take place on 26 Nov 2025 and the shares are expected to be listed on BSE and NSE on 28 Nov 2025.
- The promoters currently hold 89.37 %, which will come down to 76.15% after the IPO listing.
- Purpose of funds: ₹75.81 crore (79.8%) will be used for machinery at the Nandesari Facility I production line and the remaining amount will be allocated for general corporate purposes.
- MUFG Intime India will be the registrar for Sudeep Pharma IPO
Sudeep Pharma IPO Dates
Here are some important dates for Sudeep Pharma IPO.
Sudeep Pharma IPO Reservation
For Sudeep Pharma IPO, 35% has been reserved for retail investors.
Sudeep Pharma IPO Lot Size
Retail investors can apply for a minimum of 1 lot, which includes 25 shares costing ₹14,825. Maximum investment allowed for retail investors is 13 lots, which totals 325 shares and costs ₹1,92,725.
About Sudeep Pharma IPO
Sudeep Pharma, founded in 1989, is a leading manufacturer of pharmaceutical excipients, food-grade minerals and specialty nutrition ingredients, supplying products to over 100 countries.
The company runs six manufacturing facilities with a total capacity of 50,000 MT, producing key mineral ingredients such as calcium, iron, magnesium, zinc, potassium and sodium. It offers more than 200 products used across the pharma, food and nutrition industries.
Product Portfolio
- Pharmaceutical, Food & Nutrition products
- Specialty ingredients
- Triturates
Sudeep Pharma holds approvals from USFDA, WHO-GMP and ISO. It serves 1,100+ customers, including well-known names like Pfizer, Merck Group and Danone, across 100 countries.
Sudeep Pharma IPO Financial Performance
Sudeep Pharma reported PAT of ₹138.69 Cr on 31 March 2025 and in FY24 reported ₹133.15 Cr. Over the past 3 years, the company’s PAT has been continuously growing. All financial details are provided in the table below.
Source: Sudeep Pharma RHP
Sudeep Pharma IPO Strengths and Weaknesses
Knowing about the strengths and weaknesses of Sudeep Pharma IPO helps you make an informed decision.
- Strong R&D capabilities help the company create better and more advanced products.
- Led by an experienced team with deep knowledge of the industry.
- Modern and globally certified facilities that can scale production easily.
- Long-term relationships with major global and Fortune 500 customers.
- A leading player with a wide product range in a sector that has high entry barriers.
- Over 35% of revenue comes from the top 10 customers, creating dependence on a few clients.
- More than 60% of revenue comes from a single business segment, increasing concentration risk.
- Most operations are in Gujarat, making the company vulnerable to regional disruptions.
- Regulatory or government approval delays may slow down operations.
- Cybersecurity risks could impact sensitive education and assessment data.
Sudeep Pharma IPO GMP FAQs
What is Sudeep Pharma IPO GMP Today?
Sudeep Pharma IPO GMP today is ₹115.
What are Sudeep Pharma IPO Expected Returns?
Sudeep Pharma IPO Expected Returns are 19.39%, as of 20th November, this may change in the coming days.
When will Sudeep Pharma IPO open and close?
Sudeep Pharma’s IPO will open for subscription on 21 Nov 2025 and close on 25 Nov 2025.
What is the lot size for Sudeep Pharma IPO?
Retail Investors can bid for a minimum of 1 lot, which includes 25 shares. And one lot will cost you ₹14,825.
What is the share allotment date for Sudeep Pharma IPO?
The allotment of shares is expected to be completed by 26 Nov 2025.
Who is the registrar of Sudeep Pharma IPO?
Is Sudeep Pharma IPO good to buy?
Sudeep Pharma IPO may attract investors due to its growing PAT and strong ROE & ROCE positive GMP.
Happy investing and thank you for reading!
Disclaimer:
This website content is only for educational purposes, not investment advice. Before making any investment, it’s important to do your own research and be fully informed. Investing in the stock market includes risks, and you should carefully read the Risk Disclosure documents before proceeding. Please remember that past performance doesn’t guarantee future results, and due to market fluctuations, your investment goals may not always be achieved.
